Menthol ban would save 650,000 lives in the next 40 years

Translate to Spanish or other 102 languages!

Banning menthol flavors in cigarettes could reduce smoking by 15% by having smokers giving up tobacco products altogether or switching to e-cigarettes and other nicotine vaping products—avoiding 16,250 tobacco-related deaths per year by 2060, according to a new University of Michigan study. Image for illustration purposes

Mega Doctor News

- Advertisement -

By University of Michigan

Newswise — Banning menthol flavors in cigarettes could reduce smoking by 15% by having smokers giving up tobacco products altogether or switching to e-cigarettes and other nicotine vaping products—avoiding 16,250 tobacco-related deaths per year by 2060, according to a new University of Michigan study.

The report supports the April 2021 announcement by the U.S. Food and Drug Administration of its intention to ban menthol cigarettes and cigars nationwide. The menthol ban would not affect e-cigarettes or other flavored products. The study, published in the journal Tobacco Control, notes that additional measures such as increasing taxes on cigarettes and cigars could further reduce smoking and related deaths.

- Advertisement -

“This work is the culmination of a series of sequential projects aimed to assess the impact that a menthol ban could have on smoking, tobacco use and downstream health effects,” said Rafael Meza, one of the authors of the study and a professor of epidemiology at U-M’s School of Public Health. “Our findings show that a menthol ban could result in considerable health gains and highlight the urgency for final approval and implementation of the ban.”

The study is based on the data analysis and computational modeling infrastructure that the researchers have assembled as part of the Center for the Assessment of Tobacco Regulations. Researchers used the Smoking and Vaping Model, a simulation model they had previously developed to reflect recent cigarette and vaping products and incorporated current trends in the use of menthol and nonmenthol cigarettes. 

Then, the researchers developed a scenario with a menthol ban starting in 2021, informed by expert assessment of the potential impacts, and estimated the public health impact as the difference between smoking and vaping attributable deaths and life-years lost in the current and the menthol ban scenarios, between 2021-2060.

They found that with a menthol ban, combined menthol and nonmenthol cigarette smoking would decline by 15% by 2026. Deaths attributable to smoking and vaping were estimated to fall by about 5% and life-years lost by 8.8%—translating to 16,250 deaths per year averted and 11 million life-years gained (almost 300,000 per year) over a 40-year period.

- Advertisement -

“Recent evidence finds that a menthol ban would likely increase smoking cessation, with more limited evidence of reducing smoking initiation and switching from smoking to other products like e-cigarettes,” said David Levy, professor of oncology at Georgetown University and lead author of the paper. 

The researchers said that the effects of a menthol ban will also depend on other tobacco control policies. In particular, higher cigarette taxes would reduce smoking initiation and increase cessation, and increased enforcement of age 21 purchase laws would likely reduce smoking initiation. However, a menthol ban is likely to be very effective as a standalone policy, they said.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Honors Longtime Employee with Veteran of the Year Award

From serving our nation to caring for patients across the Rio Grande Valley, nearly 100 veterans employed throughout South Texas Health System's (STHS) 12 facilities continue to make a difference through their work in healthcare.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -